168 related articles for article (PubMed ID: 8970236)
1. Prognostic parameters in uveal melanoma: a review.
Mooy CM; De Jong PT
Surv Ophthalmol; 1996; 41(3):215-28. PubMed ID: 8970236
[TBL] [Abstract][Full Text] [Related]
2. Clinical, Histopathological and Cytogenetic Prognosticators in Uveal Melanoma - A Comprehensive Review.
Berus T; Halon A; Markiewicz A; Orlowska-Heitzman J; Romanowska-Dixon B; Donizy P
Anticancer Res; 2017 Dec; 37(12):6541-6549. PubMed ID: 29187428
[TBL] [Abstract][Full Text] [Related]
3. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.
Maat W; Ly LV; Jordanova ES; de Wolff-Rouendaal D; Schalij-Delfos NE; Jager MJ
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):505-10. PubMed ID: 18234992
[TBL] [Abstract][Full Text] [Related]
4. Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma.
Karlsson M; Boeryd B; Carstensen J; Frånlund B; Gustafsson B; Kågedal B; Sun XF; Wingren S
Eur J Cancer; 1996 Feb; 32A(2):357-62. PubMed ID: 8664054
[TBL] [Abstract][Full Text] [Related]
5. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation.
Mooy C; Vissers K; Luyten G; Mulder A; Stijnen T; de Jong P; Bosman F
Br J Ophthalmol; 1995 Feb; 79(2):174-7. PubMed ID: 7696240
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
7. Prognostic accuracy of the mean of the largest nucleoli, vascular patterns, and PC-10 in posterior uveal melanoma.
Seregard S; Spångberg B; Juul C; Oskarsson M
Ophthalmology; 1998 Mar; 105(3):485-91. PubMed ID: 9499780
[TBL] [Abstract][Full Text] [Related]
8. DNA index and % S phase fraction in posterior uveal melanoma: a 5 year prospective study of fresh tissue using flow cytometry.
Richardson RP; Lawry L; Rees RC; Rennie IG
Eye (Lond); 1997; 11 ( Pt 5)():629-34. PubMed ID: 9474308
[TBL] [Abstract][Full Text] [Related]
9. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in uveal melanoma.
Singh AD; Shields CL; Shields JA
Melanoma Res; 2001 Jun; 11(3):255-63. PubMed ID: 11468514
[TBL] [Abstract][Full Text] [Related]
11. Metastatic uveal melanoma. A morphologic and immunohistochemical analysis.
Luyten GP; Mooy CM; Post J; Jensen OA; Luider TM; de Jong PT
Cancer; 1996 Nov; 78(9):1967-71. PubMed ID: 8909318
[TBL] [Abstract][Full Text] [Related]
12. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
13. Biology of advanced uveal melanoma and next steps for clinical therapeutics.
Luke JJ; Triozzi PL; McKenna KC; Van Meir EG; Gershenwald JE; Bastian BC; Gutkind JS; Bowcock AM; Streicher HZ; Patel PM; Sato T; Sossman JA; Sznol M; Welch J; Thurin M; Selig S; Flaherty KT; Carvajal RD
Pigment Cell Melanoma Res; 2015 Mar; 28(2):135-47. PubMed ID: 25113308
[TBL] [Abstract][Full Text] [Related]
14. Uveal vs. cutaneous melanoma. Origins and causes of the differences.
Belmar-Lopez C; Mancheno-Corvo P; Saornil MA; Baril P; Vassaux G; Quintanilla M; Martin-Duque P
Clin Transl Oncol; 2008 Mar; 10(3):137-42. PubMed ID: 18321815
[TBL] [Abstract][Full Text] [Related]
15. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
16. Antigenic and cellular heterogeneity of primary uveal melanomas.
Folberg R
Arch Ophthalmol; 1986 Jun; 104(6):795, 798-9. PubMed ID: 3487304
[No Abstract] [Full Text] [Related]
17. Decreased endothelin receptor B expression in large primary uveal melanomas is associated with early clinical metastasis and short survival.
Smith SL; Damato BE; Scholes AG; Nunn J; Field JK; Heighway J
Br J Cancer; 2002 Nov; 87(11):1308-13. PubMed ID: 12439722
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous expression of melanoma-associated antigens in uveal melanomas.
van der Pol JP; Jager MJ; de Wolff-Rouendaal D; Ringens PJ; Vennegoor C; Ruiter DJ
Curr Eye Res; 1987 Jun; 6(6):757-65. PubMed ID: 3608565
[TBL] [Abstract][Full Text] [Related]
19. Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma.
de Lange MJ; Nell RJ; Lalai RN; Versluis M; Jordanova ES; Luyten GPM; Jager MJ; van der Burg SH; Zoutman WH; van Hall T; van der Velden PA
Mol Cancer Res; 2018 Dec; 16(12):1902-1911. PubMed ID: 30093564
[TBL] [Abstract][Full Text] [Related]
20. DNA index and S phase fraction in uveal malignant melanomas.
Hodge WG; Duclos AJ; Rocha G; Antecka E; Baines MG; Corriveau C; Brownstein S; Deschenes J
Br J Ophthalmol; 1995 Jun; 79(6):521-6. PubMed ID: 7626566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
